Placebo
An inactive substance or treatment (such as a sugar pill) given to the control group in a clinical trial, designed to look identical to the active treatment being tested.
In Detail
A placebo is an inactive substance, treatment, or procedure that is designed to resemble the active treatment being studied in a clinical trial. Placebos serve as a control that allows researchers to measure the true effect of the experimental treatment by comparing outcomes between participants who received the real treatment and those who received the placebo. Common placebos include sugar pills, saline injections, or sham procedures. The placebo must be indistinguishable from the active treatment in appearance, taste, and administration to maintain blinding. The "placebo effect", where participants experience real improvements simply because they believe they are receiving treatment, is a well-documented phenomenon that can influence pain perception, mood, and even measurable physiological responses. This is precisely why placebos are necessary: without them, researchers cannot distinguish the treatment's pharmacological effect from the psychological effect of receiving care. The use of placebos raises ethical considerations, particularly when an effective treatment already exists for the condition being studied. In such cases, ethical guidelines generally require that participants in the control group receive the standard treatment rather than a placebo, to avoid withholding known effective therapy. The Declaration of Helsinki and FDA guidance provide frameworks for when placebo use is ethically acceptable. Participants must always be informed through the consent process that they may receive a placebo. Understanding placebos is essential for patients considering trial enrollment.
Frequently Asked Questions
What does "Placebo" mean in clinical trials?
An inactive substance or treatment (such as a sugar pill) given to the control group in a clinical trial, designed to look identical to the active treatment being tested.
Why is "placebo" important for patients?
Understanding placebo helps patients and caregivers navigate clinical trial participation with confidence. It is part of the broader clinical research process that ensures treatments are safe and effective before reaching patients.
Related Terms
Placebo-Controlled Trial
A clinical trial that includes a placebo group to compare against the experimental treatment, helping researchers determine whether the treatment has a real effect.
Double-Blind Study
A study design where neither the participants nor the researchers know who is receiving the treatment and who is receiving the placebo, minimizing bias in results.
Randomized Controlled Trial (RCT)
A study design where participants are randomly assigned to receive either the experimental treatment or a control (placebo or standard therapy), considered the gold standard in clinical research.
Informed Consent
The process by which a potential participant learns the key facts about a clinical trial, including risks, benefits, and alternatives, before deciding whether to enroll.
this entity is one of the U.S. clinical trials and research registries concepts that recurs across this site. The definition above is the technical answer; the paragraphs below add the practical context for how the concept connects to the the NIH ClinicalTrials.gov registry data behind every per-entity page on the site.
In the the NIH ClinicalTrials.gov registry data, this concept shapes one or more of the fields that drive the per-entity grades and rankings on this site. The methodology page describes which fields feed into which output; this glossary entry documents the underlying term.
Source: ClinicalTrials.gov, 2026.